In chronic obstructive pulmonary disease (COPD), the airflow limitation is usually progressive and associated with an abnormal inflammatory response of the lungs to noxious particles or gases. The underlying chronic nonspecific inflammation is neutrophilic and characterized by the presence of increased numbers of other inflammatory cells in COPD. 1 It has been also reported that oxidative stress plays an important role in the pathogenesis of COPD by being a destructive pathology. [2] [3] [4] Thus, the determination of the oxidative stress gradually gets more important during the course of chronic diseases. The results of recent studies have indicated that during the exacerbation of COPD, antioxidant capacity is lower and the levels of lipid peroxidation products are higher than those in age-matched healthy subjects. 2, 5, 6 These lipid peroxidation products easily create reactive carbon compounds. The most important one is malondialdehyde (MDA). The determination of the level of MDA is the most practical and confidant method used for detecting and screening oxidative stress usually. 7 Malondialdehyde levels may serve as a marker of prognosis and of the success of treatment of the exacerbation of COPD. 2, 5, 6 Absolute level of free MDA in serum may be also determined with HPLC as a new method without using any reactive component 8 while total MDA level in serum is commonly determined by the TBARS process, which is currently used as a spectrophotometric method. Furthermore, in this method, it is stated that TBA forms complexes with MDA and the other many subtrates such as metal ions and organic molecules. [8] [9] [10] Here, we propose to determine and discuss MDA levels in serum by using these 2 different methods both in the exacerbation and the stable period of COPD patients, and thereby compare the specificity, sensibility, and all other characteristics of these 2 methods.
In chronic obstructive pulmonary disease (COPD), the airflow limitation is usually progressive and associated with an abnormal inflammatory response of the lungs to noxious particles or gases. The underlying chronic nonspecific inflammation is neutrophilic and characterized by the presence of increased numbers of other inflammatory cells in COPD. 1 It has been also reported that oxidative stress plays an important role in the pathogenesis of COPD by being a destructive pathology. [2] [3] [4] Thus, the determination of the oxidative stress gradually gets more important during the course of chronic diseases. The results of recent studies have indicated that during the exacerbation of COPD, antioxidant capacity is lower and the levels of lipid peroxidation products are higher than those in age-matched healthy subjects. 2, 5, 6 These lipid peroxidation products easily create reactive carbon compounds. The most important one is malondialdehyde (MDA). The determination of the level of MDA is the most practical and confidant method used for detecting and screening oxidative stress usually. 7 Malondialdehyde levels may serve as a marker of prognosis and of the success of treatment of the exacerbation of COPD. 2, 5, 6 Absolute level of free MDA in serum may be also determined with HPLC as a new method without using any reactive component 8 while total MDA level in serum is commonly determined by the TBARS process, which is currently used as a spectrophotometric method. Furthermore, in this method, it is stated that TBA forms complexes with MDA and the other many subtrates such as metal ions and organic molecules. [8] [9] [10] Here, we propose to determine and discuss MDA levels in serum by using these 2 different methods both in the exacerbation and the stable period of COPD patients, and thereby compare the specificity, sensibility, and all other characteristics of these 2 methods.
Materials and Methods
Patient groups consisted of 22 patients (male, mean age: 61.6±7.4) with acute exacerbation of COPD whom were diagnosed and managed according to "Global Initiative for Chronic Obstructive Lung Disease" (GOLD) criteria 1 in our clinic. They were all ex-smokers, and none were using alcohol and had any other disease or any medication that was likely to effect the status of the free radicals. The control group was consisted of healthy volunteers from the relatives of the patients, and medical officials (15 men, mean age of 57.8±8.5 years), and none smoked or used alcohol.
All of the patients and the control groups were informed and consented to the study, and an approval was provided by the local ethic committee (Ethic Committee of the Medical School of Firat University). A pulmonary specialist decided whether the patients were in exacerbation. This decision was based on the parameters that acutely indicated deterioration of the clinical state (increase of dyspnea, coughing and phlegm, acute decrease in effort capacity), radiological findings, respiratory function tests, arterial blood gases, and an increase of leukocyte number. It was decided that the patients exited from exacerbation state when symptoms recovered from the clinical data levels in exacerbation to the level of previous values, including improvement and stability in the blood gas values and spirometric parameters. The patients that exited from exacerbation (nearly between 8 to 14 mean days) were discharged from the hospital. Their followup examinations were done 1 month later. Blood samples were collected from the controls and patients, and each sample was divided into 2 tubes for the purpose of using both methods. To separate the serum from blood, the blood samples were centrifuged at 3,000 g for 5 minutes at 4 ο C and sample. The serum samples were stored to analyze in polyethylene tubes at -20 ο C in 7 days.
Determination of MDA by HPLC: For determination of the amount of free-pure total MDA (f-ptMDA) in serum, 0.1 mL The levels of malondialdehyde (MDA) being a product of lipid peroxidation are usually formed a complex with the TBA (2-thiobarbituric acid) called substances TBARS to be spectrophotometrically determined. In this study, the levels of MDA were determined by 2 different methods in 15 control cases and in 22 patients (male) with COPD at the exacerbation and in postexacerbative stable period.
Comparison of Serum Malondialdehyde Levels Determined by Two Different Methods in Patients With COPD: HPLC or TBARS Methods
In the exacerbation and the stable period (P<0.001), the levels of MDA determined with TBARS both in the controls and in the patients with COPD were higher than those of free-pure total MDA (f-ptMDA) determined by HPLC.
Of the results of the study, it may be suggested that the difference between the data of 2 methods depends on either the chemical form of MDA (f-ptMDA for HPLC, and MDA and others substances for TBARS method) and/or the other substances in the medium which may constitute a complex with TBA such as MDA-(TBA) 2 .
labmedicine.com 0.5M HClO 4 and 0.8 mL distilled water was added into an aliquot of 0.1 mL human serum. Addition of acid was necessary to precipitate proteins and release the MDA bound to the amino groups of proteins and other amino compounds. 7 Then, the samples were centrifuged at 4,500 g for 5 minutes and used for HPLC analysis. Twenty microliters of supernatant was taken and injected into the HPLC. 1,1,3,3-tetraethoxypropane (TEP) was used as standard MDA.
HPLC separations were accomplished at room temperature with a Cecil liquid chromatography system (Series 1100) consisting of a sample injection valve (Cotati 7125) with a 20 µL sample loop, an ultra-violet (UV, at 254 nm) spectrophotometric detector (Cecil 68174), integrator (HP 3395), and a Supelcosil C18 column (5 µm particle and 80 o A pore size; column 250 x 4.6 ID) with mixture of 30 mmol KH 2 PO 4 and methanol (65%-35%, H 3 PO 4 by pH=4), mobile phase at 1.5 mL min -1 flow rate. 8 Calibration plot for MDA solutions prepared at the different concentrations are shown in Figure 1 .
Determination of MDA by TBARS: The proteins in 0.15 mL serum were first precipitated by using sulphuric and phosphotungstic acid and then the levels of MDA were measured in these samples. Precipitate obtained incubated with TBA in a water bath at 95°C for 60 minutes in an environment with oxygen and pH=3.4. The colored complex that occurred was refrigerated to room temperature. Then the complex was taken into n-buthanole phase. At the end, the complex of MDA-(TBA) 2 was measured by using Shimadzu UV-1201V spectrophotometry at 532 nm. 11 TEP (1,1,3,3-tetraethoxypropane) was used as standard MDA. Calibration plot for MDA solutions prepared at the different concentrations are shown in Figure 2 .
Of standard TEP solution (10 µg/mL), 0.2 ml was added in 0.1 mL serum. Then, 0.1 mL of 0.5M HClO 4 solution was added to this solution. Total volume was completed to 1.0 mL with distilled water. Thus, the sample of serum appended with standard MDA was prepared. In the same way, total volume (by adding 0.1 mL of 0.5M HClO 4 solution into 0.1 mL serum sample) was completed to 1.0 mL with distilled water. Thus, the normal serum was prepared.
Two micrograms/milliliter concentration for the TEP solution used as standard MDA was prepared. Peak heights for all solutions were determined by HPLC. Recovery % was calculated from the following relation by taking the data in the linear range. The calculation of recovery % was repeated 3 times with different solutions. We note that recovery % in TBARS method was also calculated from the same relation and in the similar manner. The relation is given as Rec = A -B x 100 C Where A is the serum standard MDA, B is standard MDA, and C is normal serum. Recovery % is Rec.
All chemicals and reagents used (from Merck) were analytical grade. The SPSS software (SPSS, Chicago, IL) was used for statistical analyses. Results of the groups were expressed as means ± SD. The results for exacerbation, stable period, and controls obtained with both (TBARS and HPLC) methods were compared with each other by the paired-t test. To compare both stable period and exacerbation data with controls, the 2-sample independent t-test was used. Cases were compared to controls once during disease exacerbation, and once during a period of remission. To preserve the overall probability of a type I error, P-values were adjusted downward and tests were considered significant at P<0.025.
Results
Recovery % values determined for HPLC and TBARS methods, respectively, were found as 98.5% and 84.2%. Spirometric and arterial blood gas analyses of the patients with COPD are presented in Table 1 .
The MDA levels in serum were spectrophotometrically (TBARS) determined as 7.15±1.21 nmol/mL in the exacerbation, 5.22±1.56 nmol/mL in the post-exacerbative stable period, and 3.46±0.57 nmol/mL in controls. The MDA levels determined with high performance liquid chromatography (HPLC) in the same samples of serum were obtained as 2.18±0.64 nmol/mL in the exacerbation and 1.16±0.45 nmol/mL in the postexacerbative stable period, and 0.72±0.20 nmol/mL in controls. The levels of MDA in the exacerbation were significantly found higher than stable period values in both methods (P<0.001) ( Table 1) .
The MDA levels determined by TBARS method in the controls and COPD patients either in the exacerbation or in the stable period were higher than results determined by HPLC in the identical samples (P<0.001) as given on Table 2 . R values of the regression analyses for serum MDA amounts determined by TBARS and HPLC in the patients with COPD were R=0.81 (R 2 =0.66) in exacerbation and R=0.84 (R 2 =0.70) in the stable period. R values obtained in both periods exhibited significant correlation (R>0.5) (Figure 3 and 4) . 
Discussion
Determination of free oxygen radicals' generation process gains importance because of its role in the pathogenesis of a lot of pathological processes and its effect on mortality and morbidity. 12, 13 Free oxygen radicals cause lipid peroxidation. The end product of lipid peroxidation is MDA. Determination of MDA allows detection of the degree of lipid peroxidation and level of free oxygen radicals indirectly. 14 Generally, MDA level is determined by using TBARS method. Determination of MDA with TBA is usually made at 532 to 535 nm wavelength spectrophotometrically after MDA-(TBA) 2 complex occurred. 11 The sensitivity and specificity of TBARS method currently in use may not be adequate because it is reported that some substances (eg, some metal ions and organic molecules), which may present in the serum medium except MDA, may cause chemical interference by forming complexes with TBA. 10, [15] [16] [17] [18] Therefore, this method is also criticized because of its low specificity, sensitivity, and reproducibility. 19 Recently, HPLC, a more sensitive, specific, and reproducible method in determination of MDA, is preferred as an alternative method by a lot of researchers. HPLC can be applied without a complex formation and any other initial process, and it is not affected by chemical interference, unlike TBA. 8, 20 It is argued that the use of HPLC is recommended due to its analytical sensitivity. 8, 17 On the other hand, repeatability of experimental assays is an important qualification for its safety. A mean value of 3 measurements, at least, is required for the evaluation of TBARS, because it has no reproducibility property. However, only 1 measurement with HPLC is safe enough because of its reproducibility. 21 The decline in MDA levels seen in the stable period when compared with the exacerbations values in the patients with COPD may depend on the reduction of the severity of oxidative stress and inflammatory process. 22 In this study, there was also a significant difference among the values determined by each of the methods both in the exacerbation and stable period of patients with COPD compared with the control group as shown in Table 2 (P<0.001).
There were significant correlations between TBARS and HPLC methods for serum MDA amounts both in the exacerbation (R=0.81) and the stable period (R=0.84) in the patients with COPD (R>0.5) (Figure 3 and 4) . However, levels of MDA determined by TBARS and HPLC in the same samples showed considerable differences (P<0.001). The values of MDA determined by TBARS were higher then the results obtained by HPLC. This status is clarified with chemical interferences in TBARS methods, because the HPLC method determines fptMDA while TBARS determines MDA and other some substances.
Finally, HPLC is also as sensitive as TBARS according to our results, but it is much more specific then TBARS. HPLC method which determines f-ptMDA need minimal chemical substance and serum sample and a short time for preparations of experimental samples. In addition, it also has the features such as reproducibility of the results and cost effectiveness.
In conclusion, it may be suggested that HPLC should be preferred for determination of free MDA levels because of its safety sensitivity, specificity, and reproducibility in clinical laboratories according to our results obtained from the patients with COPD. Figure 3_The regression graphic for serum MDA levels determined by TBARS and HPLC in exacerbation in the patients with COPD.
Figure 4_The regression graphic for serum MDA levels determined by TBARS and HPLC in stable period in the patients with COPD.
